FFA
DSGN icon

Farther Finance Advisors’s Design Therapeutics DSGN Stock Holding History

Farther Finance Advisors’s Portfolio DSGN Stock Details DSGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$289 Sell
20
-366
-95% -$4.56K ﹤0.01% 5652
2026
Q1 		$4.25K Buy
386
+1
+0.3% +$10 ﹤0.01% 4572
2025
Q4 		$3.61K Hold
385
– – ﹤0.01% 4464
2025
Q3 		$2.9K Buy
385
+366
+1,926% +$1.83K ﹤0.01% 3991
2025
Q2 		$64 Hold
19
– – ﹤0.01% 4354
2025
Q1 		$68 Hold
19
– – ﹤0.01% 4103
2024
Q4 		$117 Hold
19
– – ﹤0.01% 3760
2024
Q3 		$102 Buy
+19
New +$89 ﹤0.01% 3774

Other funds holding DSGN

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
APW
Allied Private Wealth Boca Raton, Florida $156M AUM
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors's DSGN Position: Q2 2026 in Review

Farther Finance Advisors reduced its Design Therapeutics (DSGN) stake by 95% in Q2 2026, selling an estimated $4.56K and leaving 20 shares worth $289. The position accounts for ﹤0.01% of the portfolio, ranked #5652.

Farther Finance Advisors first reported a position in DSGN in Q3 2024 and has held it in 8 quarters since. The position peaked at $4.25K in Q1 2026. 8 funds tracked by Wall St. Rank hold DSGN as of Q2 2026.

  • Farther Finance Advisors held 20 shares of Design Therapeutics worth $289 as of Q2 2026.
  • Farther Finance Advisors sold 366 Design Therapeutics shares in Q2 2026, an estimated $4.56K.
  • Design Therapeutics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #5652 holding.
  • Farther Finance Advisors first reported a position in Design Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • Farther Finance Advisors's Design Therapeutics position peaked at $4.25K in Q1 2026.
  • 8 funds tracked by Wall St. Rank held Design Therapeutics as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.